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Abstract 
The first electrochemical immunosensor for the determination of 8-isoprostane (8-iso 
prostaglandin F2α, ISO), one of the most reliable biomarkers of lipid peroxidation in the 
human body and of aging related to Alzheimer´s disease or atherosclerosis is reported in 
this article. Disposable screen-printed carbon electrodes modified with carboxylated 
carbon nanohorns (CNHs) were employed as scaffolds for covalent immobilization of a 
specific anti-ISO antibody). A competitive immunoassay involving ISO and HRP-
labeled antigen was designed and the determination of ISO was carried out by 
amperometry at -200 mV using the H2O2/hydroquinone (HQ) system. Under the 
optimized conditions, the immunosensor provides a linear response for ISO (r
2
 = 0.998) 
extending up to 700 pg/mL, which is suitable for the determination of the target 
compound in human serum. The analytical performance of the immunosensor improves 
that claimed for ELISA kits in terms of linearity of the calibration plot, precision, with 
RSD values lower than 1 % , and assay time (1h 30min), and exhibits a low limit of 
detection, 12 pg/mL,  a long storage stability (30 days), and an excellent selectivity 
against other proteins that may be found in human serum. The analytical utility of the 
developed immunosensor was demonstrated by determining ISO in two types of human 
serum samples: lyophilized spiked serum, and real human serum from healthy male and 
female individuals with good results.  
Keywords: Aging biomarkers, electrochemical immunosensors, 8-isoprostane, 
prostaglandin 
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1. Introduction 
Isoprostanes are prostaglandin–like compounds produced through the oxygen radical 
induced peroxidation of tissue phospholipids and lipoproteins [1]. Among them, 8-
isoprostane (8-iso-prostaglandin F2α, ISO) (Figure 1), a stable product of oxidative 
stress, is one of the most reliable biomarkers of lipid peroxidation in the human body 
[2], and of aging related to Alzheimer´s disease or atherosclerosis [3]. Although 
detectable quantities of isoprostanes are usually present in tissues and biological fluids 
including plasma, saliva and urine, their levels increase as the oxidative damage 
increases [4]. Relatively high isoprostanes concentrations appear in smokers, and in 
patients suffering cardiovascular diseases, diabetes, obesity, hypercholesterolemia, 
metabolic syndrome [5], or cancer [6].  Although GC–MS and LC–MS/MS are the 
recommended techniques for the determination of 8–isoprostane in clinical samples 
[7,8], the methods, mainly applied to urine, are characterized by their high cost, 
extensive sample extraction and low throughput. As an alternative, ELISA 
immunoassays are also used. Table 1 summarizes the analytical characteristics claimed 
for various commercial ELISA kits for the determination of ISO. All configurations 
used involve competitive-type immunoassays and most of them use HRP-labeled 
immunoreagents and colorimetric detection upon H2O2 addition in the presence of 
3,3´,5,5´-tetramethylbenzidine (TMB). Less common are those using 
acetylcholinesterase (AChE) or alkaline phosphatase-labeled ISO. The addition of 
Ellman´s reagent containing the substrate of AChE or p-nitrophenyl phosphate, 
respectively, allow the colorimetric detection to be performed. Despite the claimed 
advantages of immunosensors versus ELISA concerning higher sensitivity and lower 
detection limits, better precision, and shorter assay times [9,10], no immunosensors for 
the determination of ISO have been described in the literature so far. 
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Figure 1. Structure of 8-isoprostane (8-iso prostaglandin F2α, ISO). 
On the other hand, single-walled carbon nanohorns, SWCNHs (or simply CNHs), are a 
relatively new type of carbon allotrope consisting of a unique horn-shaped graphene 
with a diameter of 2-5 nm and a length of 40–50 nm [11]. CNHs assemble to form 
nanostructures shaped like dahlia flowers [12], with a diameter around 100 nm, that 
enables an easy dispersion in liquids [13]. Another important feature is that production 
of CNHs is performed in the absence of metal catalysts, so that they can be used directly 
without post treatment or purification [14]. Moreover, CNHs possess high conductivity, 
large surface area, and abundant oxidizable defects that provide a great number of 
oxygenated groups affordable for biomolecules immobilization [15]. Despite these 
interesting properties, scarce applications have been reported up to date related with the 
preparation of electrochemical immunosensors involving CNHs functionalized 
electrodes [16]. A competitive immunoassay design for the determination of 
microcystin-LR (MC-LR)  involving covalent immobilization of the antigen to oxidized 
CNHs and the use of HRP-anti-MC-LR was reported by Zhang et al [17]. More 
recently, a sandwich-type impedimetric immunosensor for α-fetoprotein (AFP) was 
prepared by linking HRP and GOx enzymes to CNHs and biocatalyzed precipitation in 
the presence of 4-chloro-1-naphthol and H2O2 which led to a significant enhancement of 
the signal from Fe(CN)6
3-/4- 
redox couple [18]. Our group also used carboxylated CNHs 
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to construct electrochemical platform for the preparation of an immunosensor for 
fibrinogen (Fib) [19]. The approach involved the use of HOOC-CNHs deposited onto a 
SPCE to covalently immobilize Fib, and the establishment of an indirect competitive 
assay with horseradish peroxidase labeled Fib. A composite combining CNHs and 
alginic acid was also used to develop a sandwich-type enzyme-free immunosensor for 
carcinoembryonic antigen (CEA) [20]. The large concentration of immobilized 
antibodies provided a high sensitivity that was enhanced by using magnetic NiCo2O4 
NPs decorated with hematin as labels for the secondary antibodies. A Chitosan/CNHs 
composite demonstrated to be also a suitable electrochemical platform to construct an 
electrochemical  immunosensor for alpha-fetoprotein (AFP) [21].  
In this work the first electrochemical immunosensor for the determination of ISO is 
reported. A simple and rapid strategy was developed involving the use of disposable 
screen-printed carbon electrodes modified with carboxylated CNHs as scaffolds for 
covalent immobilization of a specific antibody (anti-ISO). A competitive immunoassay 
involving the target antigen (ISO) and HRP-labeled antigen (HRP-ISO) was employed. 
ISO quantification was carried out by amperometry at -200 mV (vs. Ag pseudo-
reference electrode) using the H2O2/hydroquinone (HQ) system. Therefore, the 
reduction current of the generated quinone at the SPCE surface was the analytical 
readout. All the steps involved in the preparation and performance of anti-ISO-
CNHs/SPCE immunosensor were optimized and, under the optimized conditions, ISO 
could be determined with a high sensitivity. The analytical utility of the developed 
immunosensor was demonstrated by determining ISO in two types of human serum 
samples: lyophilized spiked serum, and real human serum from healthy male and female 
individuals with good results. 
2. Experimental  
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2.1. Reagents and solutions 
The rabbit anti-ISO capture antibody, the antigen (ISO), and the HRP-labeled antigen 
(HRP-ISO) used were the reagents included in the ELISA kit OxiSelect
TM
  (STA-337) 
from Cell Biolabs. Working solutions from the antibody were prepared in a 25 mM 2-
(N-morpholino) ethanesulfonic (MES, Gerbu) buffer solution of pH 5.0. Sample Diluent 
from Cell Biolabs was the solvent used to prepare ISO and HRP-ISO working solutions. 
CNHs were synthesized in the absence of metallic catalysts by graphite ablation with a 
CO2 laser under argon atmosphere at 760 Torr and room temperature. The purity was 
higher than 90% and the 10% impurity was micrometer-sized graphitic balls [22]. 
CNHs oxidation was performed by treatment with a 30% H2O2 aqueous solution at 
≈100ºC [23]. Activation of the carboxylic groups of CNHs for further immobilization of 
capture antibodies was made by using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC) and N-hydroxysulfosuccinimide (NHSS) (Acros Organics). 
Bovine serum albumin (BSA) from Gerbu was used as blocking agent. Compounds 
tested as potential interfering substances were:  adiponectin (APN), ceruloplasmin (Cp), 
interleukin-6 (IL–6), interleukin-8 (IL–8) (Abcam), bilirubin (BR) (Aldrich), cholesterol 
(Chol), creatinin (CR), hemoglobin (HB) (Sigma), transforming growth factor β1 
(TGF–β1), tumor necrosis factor α (TNF–α) (R&D Systems), and C reactive protein 
(CRP) (Fitzgerald). Hydrogen peroxide (Aldrich, 30% (w/w)) and hydroquinone (HQ) 
(Sigma) were used for the amperometric measurements. Deionized water from a 
Millipore Milli–Q (18.2 MΩ·cm at 25 ºC) purification system was also used. 
Samples analyzed were lyophilized human serum (S2257, Sigma) spiked with 30, 35 
and 40 pg/mL ISO, and real human serum samples from healthy male and female 
individuals (BBI Solutions, SG610–2 y SG609–2, respectively). Validation was 
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accomplished by comparing the results with those obtained by using the OxiSelect
TM
 
ELISA kit (STA-337) from Cell Biolabs. 
2.2. Apparatus and electrodes 
Amperometric measurements were made with an INBEA potentiostat using the IbGraph 
software (INBEA S.L., Madrid, Spain). Screen-printed carbon electrodes (SPCEs, 110 
DRP,  4 mm) from DropSens (Oviedo, Spain) were used as working electrodes. These 
electrodes are provided with a silver pseudo-reference electrode and a carbon counter 
electrode. Electrochemical impedance spectrocopy was carried out with an Autolab type 
III potentiostat (Ecochemie) controlled by FRA2 software. Incubation steps were 
performed at 25 °C using an Optic Ivymen System constant temperature incubator 
shaker (Comecta S.A.) and pH measurements were made using a Crison Basic 20+ 
pHmeter. A P-Selecta ultrasonic bath, an MPW-65R centrifuge (MPW Med. 
Instruments), and a Vortex homogenizator from Heidolph were also used. Absorbance 
measurements in the ELISA method were made using a Sunrise
TM
 Tecan microplate 
reader provided with the Magellan software. All experiments were performed at room 
temperature. 
2.3. Procedures 
2.3.1. Preparation of the immunosensor 
Oxidized CNHs (1 mg) were suspended in 2 mL of deionized water in an Eppendorf 
tube and ultrasonicated for 90 min. Once homogenized, a 5-μL aliquot was transferred 
to the electrode surface and dried under IR radiation. This operation was repeated by 
depositing another 5-μL aliquot. Activation of CNHs carboxyl groups was made by 
addition of 5 μL of a 0.1 M each EDC/NHSS mixture solution, prepared in 25 mM MES 
buffer solution of pH 5.0, onto CNHs/SPCE, and let to stand during 30 min. Thereafter, 
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immobilization of the capture antibody was accomplished by adding  5 μL of a 1/600 
diluted anti-ISO solution prepared in 25 mM MES buffer solution of pH 5.0, allowing 
incubation for 60 min at 25°C. Then, the anti-ISO-CNHs/SPCE immunosensor was 
washed with deionized water and allowed drying in air. Next, a blocking step was 
applied by adding 5 μL of a 2 % BSA solution and incubating for 30 minutes followed 
by washing with water. Finally, the resulting immunosensors were preserved by adding 
50 µL of 50 mM phosphate buffer solution of pH 6.0 until use. 
2.3.2. Immunoassay at anti-ISO-CNHs/SPCE 
A  competitive immunoassay scheme was employed for the determination of ISO. A 
mixture solution of the antigen (ISO) and the labeled antigen (HRP-ISO) was prepared 
in an Eppendorf tube with 5 μL of stardard ISO solutions of variable concentration or 
the sample, and 5 μL of a 1/250 diluted HRP-ISO solution. Then, 5 µL from this 
mixture solution were dropped onto the as prepared anti-ISO-CNHs/SPCE and 
incubated for 45 minutes. Amperometric measurements were obtained after addition of 
45 μL of a 1 mM HQ solution prepared in a 50 mM phosphate buffer solution of pH 6.0, 
and by applying a detection potential of -200 mV. Once the background current was 
stabilized (200 s approximately), a 5-μL aliquot of 50 mM hydrogen peroxide solution 
was added and, after a period of 200 s for allowing the enzymatic reaction to take place, 
the reduction current of the formed quinone was measured.  
2.3.3.  Analysis of  human serum 
As indicated above, two types of human serum samples were analyzed. Lyophilized 
solid serum was reconstituted in deionized water  and, once spiked, it was 1:1 diluted 
with HRP-ISO solution. No further treatment was necessary. A simple treatment was 
applied to real serum samples. It consisted of the addition of 100 μL of 10 M NaOH to 
400 μL of sample and incubation for two hours at 45 ºC. This treatment was applied to 
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hydrolyze lipoprotein and phospholipid coupled ISO in order to measure both free and 
esterified ISO. Then, 100 µL of 10 M HCl were added to assist precipitation of 
lipoproteins and phospholipids. Centrifugation at 12,000 rpm for 5 min was carried out 
and the supernatant should be in the 6-8 pH range. In both cases, the determination of 
ISO was carried out by interpolation of the amperometric responses measured for the 
samples into the calibration plot constructed with ISO standards. Furthermore, 
validation of the results for real serum samples was accomplished by comparison with 
those provided by an ELISA method for human ISO from Cell Biolab. In this case, the 
protocol indicated in the suppliers directions was followed. In brief, this consisted of 
pipetting a mixture solution of ISO standards or samples and HRP-ISO into the anti-ISO 
coated-well plates and leaving an incubation time of 60 min. Then, colour development 
was achieved by addition of TMB substrate solution and after 20 min, an acid "stop 
solution" was added, and the absorbance was measured at 450 nm. 
 
3. Results and discussion 
The synthesis and characterization of CNHs were performed as described previously 
[19]. As indicated in the Experimental section, 30 % aqueous H2O2 was used for CNHs 
oxidation and generation of carboxylic acid groups [23] for further antibodies 
immobilization. The fundamentals of the different steps involved in the immunoreaction 
occurring on the activated functionalized CNHs-modified SPCE as well as of the 
amperometric transduction strategy are schematically depicted in Figure 2. Once 
carboxylated CNHs were adsorbed on the electrode surface, anti-ISO antibodies were 
covalently immobilized and the remaining active sites on the SPCE surface blocked 
with BSA. Thereafter, a competitive immunoassay strategy was designed by dropping 
onto the anti-ISO-CNHs/SPCE immunosensor a mixture solution of the target analyte 
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and HRP-ISO. The amperometric response for ISO quantification was measured upon 
addition of H2O2 as HRP substrate in the presence of HQ as the redox mediator. 
 
Figure 2. Schematic display of the different steps involved in the preparation and 
functioning of the anti-ISO-CNHs/SPCE immunosensor 
 
 3.1. Optimization of experimental variables involved in the performance of the 
immunosensor 
Variables involved in the preparation of the immunosensor and its electrochemical 
performance were optimized. The evaluated variables were: a) loading of anti-ISO 
antibody immobilized onto CNHs/SPCE; b) concentration of HRP-ISO conjugate; c) 
time for competition between ISO and HRP-ISO for the binding sites of the capture 
antibody; d) reagents and incubation time used for blocking the remaining unmodified 
sites on the electrode surface. Details on the optimization studies are provided in the 
EDC/NHSS
HOOC-CNHs/SPCE BSA
ISO +  HRP-ISO
E
i
e-
H2O
H2O2
H R PredH R Pox
H Qred HQ ox
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Supporting Information and in Figures S1-S4. Other variables such as the amount of 
CNHs adsorbed onto the electrode surface (5 μg) or the composition of the H2O2/HQ 
system and the detection potential were optimized in previous works [19, 24]. 
 
3.2. Characterization of the immunosensor by electrochemical impedance 
spectroscopy and cyclic voltammetry  
Electrochemical impedance spectroscopy (EIS) was employed to monitor the different 
steps involved in the preparation of the immunosensor. Figure 3a shows the Nyquist 
plots recorded for bare SPCE, HOOC-CNHs/SPCE, anti-ISO-CNHs/SPCE, and HRP-
ISO-anti-ISO-CNHs/SPCE, using 5 mM Fe(CN)6
3-/4-
 in 100 mM KCl of pH 7.0 as the 
redox probe. As it can be seen, the charge transfer resistance at the bare SPCE (curve 1) 
was notably higher (RCT = 284 ohm) than that measured for the CNHs//SPCE (curve 2, 
RCT = 15 ohm) due to the expected electron transfer promotion occurring at carbon 
nanohorns-modified electrodes. The resistance increased to 45 ohm when the anti-ISO 
antibodies were deposited onto the CNHs/SPCE surface (curve 3), as a consequence of 
the isolating effect provoked by the biomolecules. It is interesting to remark that despite 
this isolating effect, the RCT value is notably low which points out the electron transfer 
promotion caused by the presence of CNHs as electrode modifying material. 
Subsequent immobilization of the HRP-labeled antigen led to a further resistance 
increase (curve 4) (RCT = 338 ohm), due to the lower conductivity of the resulting 
biosurface. Figure 3b shows cyclic voltammograms for the same redox probe solution 
recorded at SPCE. HOOC-CNHs/SPCE, anti-ISO-CNHs/SPCE, and HRP-ISO-anti-
ISO-CNHs/SPCE. Results are consistent with those obtained by EIS. A noticeable 
increase in the oxidation and reduction peak current values for Fe(CN)6
3-/4-
 was 
observed when SPCEs were modified with HOOC-CNHs (voltammogram 2) which is  
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attributed to the improved electron transfer upon modification with CNHs. Surface 
immobilization of anti-iSO and formation of the immunocomplexes with HRP-ISO 
(voltammograms 3 and 4, respectively) produced slight decreases in the peak current 
values most likely due to the high conductivity of the modified electrode surface despite 
immobilization of biomolecules. These results confirmed the suitability of the used 
procedures for the electrode modification and immobilization of anti-ISO antibodies 
onto CNHs/SPCEs. 
 
Figure 3. Nyquist plots (a) and cyclic voltammograms (b) recorded for (1) bare SPCE, 
(2) CNHs//SPCE, (3) anti-ISO-CNHs/SPCE, and (4) HRP-ISO-anti-ISO-CNHs/SPCE 
with 5 mM Fe(CN)6 
3−/4−
 in 100 mM KCl of pH 7.0. 
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3.3. Analytical figures of merit of the immunosensor 
Figure 4 shows the linear calibration plot (r
2
 = 0.998) for ISO constructed by 
amperometry at -0.20 V with the anti-ISO-CNHs/SPCE immunosensor. The 
corresponding equation is: ip, nA = (850 ± 8) [ISO, ng/mL] + (623 ± 3 nA), and the 
linear range extends up to 700 pg/mL ISO. Interestingly, this range is suitable for the 
determination of the target compound in human serum since the concentration levels 
found in healthy individuals are comprised between few tens and few hundreds of 
pg/mL [25, 26]. The limit of detection, 12 pg/mL, was calculated as the lowest 
concentration that can be statistically discriminated from zero, according to the 3·x s  
criterion, where s was estimated as the standard deviation (n=10) for the blank 
(measurements in the absence of ISO) in concentration units (pg/mL). The limit of 
quantification achieved, 10·x s , was 19 pg/mL. 
 
 
 
 
 
 
 
 
 
 
Figure 4. Calibration plot for ISO constructed with the anti-ISO-CNHs/SPCE 
immunosensor. See text for the experimental conditions.  
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The reproducibility of the amperometric measurements was tested by repetitive 
measurements carried out for 0 and 50 pg/mL ISO carried out with six different 
immunosensors. Relative standard deviations values, RSD, of 0.36 and 0.35 %, 
respectively were calculated for immunosensors prepared in the same day, while RSD 
values of 0.53 and 0.40 %, respectively, were found for immunosensors prepared in 
different days. These results demonstrated an excellent accuracy of the amperometric 
measurements and indicated that the proposed method for the immunosensor 
preparation was reliable and reproducible. When these analytical figures of merit are 
compared with data provided for commercial ELISA kits using similar 
immunoreagents, some noticeable differences become apparent. ELISA kits usually 
provide non-linear dynamic ranges covering from several tens to thousands of pg/mL 
with minimum detectable concentrations (MDC) of tens (or even one hundred) pg/mL. 
These parameters are calculated mostly from nonlinear logarithmic plots and the 
precision levels are around 10% or higher. It is important to note that the criteria used to 
calculate the MDC values for these kits are rarely given in the commercial protocols. 
Moreover, the time lasted for the assay is remarkably longer with ELISA kits which 
mostly require 2 h 30 min versus 1h 20 min needed when the immunosensor is used 
(counting, in both cases, since the immobilization of capture antibody). Therefore, it can 
be concluded that the analytical performance of the developed immunosensor, covering 
a wide linear range of clinically relevant ISO concentrations, improves, in general 
terms, the analytical performance claimed for ELISA kits. 
The storage capability of the anti-ISO-CNHs/SPCE bioelectrode was also tested. 
Different immunosensors were prepared on the same day and stored at -20 ºC under dry 
conditions. Then, the immunosensors were used in different days to measure solutions 
without ISO. A control chart was constructed (Figure S5) by setting as control limits ± 
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3s, where s was the standard deviation of the measurements (n=10) carried out on the 
first day. The immunosensor responses remained inside the control limits for 30 days, 
decreasing for longer storage periods probably as a consequence of the loose of activity 
of the antibody. These results suggested the possibility of preparing a set of anti-ISO-
CNHs/SPCEs immunosensors and keeping them under storage until their use for the 
analysis of samples was requested. 
Regarding the selectivity of the immunosensor, it is important to remind that anti-ISO 
antibodies used were the same that those employed in the ELISA kit OxiSelect
TM
  
(STA-337) from Cell Biolabs. These antibodies exhibited a high specificity toward ISO 
(8-isoprostane, 8-iso-PGF2α), versus other types of similar compounds, with cross-
reactivity factors of 4.6 % (PGF1α) or 1.8% (PGF2α), and much lower CR% for other 
derivatives [http://www.cellbiolabs.com/8-iso-prostaglandin-f2a-assay]. Therefore, we  
tested the additional selectivity of the capture antibody by measuring the amperometric 
responses of the immunosensor for 0 and 50 pg/mL ISO in the presence of other 
proteins: adiponectin (APN), bovine serum albumin (BSA), bilirubin (BR), cholesterol 
(Chol), ceruloplasmin (Cp), transforming growth factor β1 (TGF), tumoral necrosis 
factor alpha (TNF), hemoglobin (Hb), interleukin-6 (IL-6), and interleukin-8 (IL-8) at 
concentration levels that can be found in serum of healthy individuals. Figure 5 shows 
clearly as no significant differences were apparent between the currents measured in the 
absence or in the presence of these compounds, thus demonstrating the practical 
specificity of the immunosensor for the determination of ISO. 
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Figure 5. Interferences study: 0 (grey) and 50 (white) pg/mL ISO in the presence of  20 
μg/mL adiponectin (APN), 5 mg/mL BSA, 20 μg/mL cholesterol (Chol), 500 μg/mL 
ceruloplasmin (Cp), 500 pg/mL transforming growth factor β1 (TGF), 100 pg/mL  
tumor necrosis factor α (TNF), 50 μg/mL hemoglobin (Hb), 50 pg/mL interleukin 6 
(IL–6) , 30 pg/mL interleukin 8 (IL–8). 
 
 
3.4. Determination of ISO in human serum 
The developed immunosensor was applied to the determination of ISO in two types of 
human serum, lyophilized spiked serum, and real human serum from healthy male and 
female individuals by applying the procedures described in section 2.3.3. Regarding 
lyophilized serum, the possible existence of matrix effects was initially evaluated by 
constructing a calibration plot for reconstituted serum and spiked with ISO over the 0 to 
40 pg/mL concentration range. The equation for the corresponding linear calibration 
graph was: ip, nA = (896 ± 3) [ISO, ng/mL)] + (624 ± 1, nA). No statistically significant 
difference was found with the slope value of the calibration plot constructed with ISO 
standard solutions as the Student`s texp value, 1.247, was lower than the tabulated one, 
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ttab = 4.303 for a 0.05 significance level. Therefore, no significant matrix effect was 
found and the determination of ISO could be carried out by interpolation of the current 
values measured for the serum samples into the calibration plot constructed with ISO 
standard solutions. Table 2 summarizes the results obtained by triplicate for lyophilized 
serum spiked at three different concentration levels. Recoveries ranged between 95 and 
101%, indicating the reliability of the approach to determine low ISO concentrations in 
this kind of sample following a very simple working protocol. 
Furthermore, two real human sera from male and female healthy individuals were also 
analyzed. As it was described in the Experimental section 2.3.3, a simple treatment was 
applied to these samples with the aim of hydrolizing lipoproteins and phospholipids to 
which ISO could be bound. This treatment was that recommended for the ELISA test 
for human ISO by Cell Biolab [http://www.cellbiolabs.com/8-iso-prostaglandin-f2a-
assay]. Once verified the absence of matrix effects, the determination of ISO was 
carried out by interpolation of the amperometric responses for the samples into the 
calibration plot constructed with ISO standards. Validation of the obtained results was 
accomplished by comparing them with those provided by the OxiSelect
TM
 (STA–337) 
ELISA kit from Cell Biolabs following the procedure specified in Section 2.3.3. The 
results obtained by both methods are summarized in Table 2. RSD values (n=6) were in 
all cases lower than 2% exhibiting an excellent precision. The concentrations found 
were also statistically compared by means of the Struden´t t test, obtaining texp values of 
1.714 (male) and 1.107 (female) which were lower than tabulated t (2.228). These 
results confirm that no significant differences were apparent between both 
methodologies at a significance level of 0.05. All these results demonstrate clearly the 
usefulness of the developed immunosensor to determine ISO at clinically relevant 
concentrations in human serum. 
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4. Conclusions 
The first immunosensor for the determination of the aging biomarker 8-isoprostane is 
reported in this paper. In order to improve the analytical performance of the 
immunosensor an electrochemical platform consisting of disposable SPCE modified 
with carboxylated CNHs has been used as scaffold for the covalent immobilization of 
specific anti-ISO antibodies. Using a competitive immunoassay, ISO can be determined 
in human serum with a high sensitivity derived not only from the high conductivity of 
CNHs but also because of the large number of oxygenated moieties present on the 
CNHs-modified electrode surface allowing subsequent high loading of capture 
antibodies. The analytical performance exhibited by the electrochemical immunosensor 
is excellent, improving, in general terms, that provided by ELISA kits. The usefulness 
of the immunosensor was demonstrated by determining ISO in lyophilized spiked 
serum, and real human serum from healthy male and female individuals with results in 
statistic agreement with those found by applying an ELISA kit. 
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Table 1. Analytical characteristics reported for various  ELISA immunoassays for ISO 
determination. 
Type of 
immunoass
ay 
ELIS
A 
kit 
Dynamic range, 
pg/mL 
MDC*, 
pg/
mL 
Precisio
n, RSD 
% 
(inter/intra assays) 
Ass
ay 
tim
e 
Direct 
competitiv
e between  
Eagle 
Bioscience 
(8IS39-K01) 
10 - 
5000 
10 - 2 h 
30 
min 
ISO and HRP-ISO Cayman 
Chemical  
(516351) 
0.8 - 500 2.7 7.2% / 15.5% 2 h 
Substrate: TMB Saphire 
Bioscience 
(133-16456) 
1.4 - 
3000 
18 ≤10% / ≤12.6% 3 h 30 min 
 Neogen 
Corporation 
(430110) 
50 – 
1000
0 
30 ≤10% / ≤10% 2 h 40 min 
 Cusabio 
(CSB-
E12100h) 
78 - 
5000 
19.5 <15% / <15% 2 h 30 min 
 EIAab 
(E0701h) 
1.56 
- 
100 
1 - 4 h 30 min 
 Abcam 
(ab175819) 
5 - 
5000 
1 - 2 h 30 min 
 Oxford 
Biomed. 
Res. (EA84) 
50-
100 
- - 2 h 30 min 
 Abbexa Ltd 
(abx055460) 
16 -
1000 
5 - 2 h 30 min 
 US 
Biological 
(I9050) 
100-
1000 
100 - 2 h 30 min 
 Abnova 
(KA0443) 
50-
1000
0 
100 - 2 h 40 min 
 Invitrogen 
(KHP0041) 
500-
1600
0 
100 3.8% / 4.6% 2 h 20 min 
 Northwest 
(NWK-
IS002) 
50-
1000
0 
50 - 2 h 30 min 
 Detroit 
R&D, Inc 
(8Iso1) 
500-
1600
0 
100 - 2 h 30 min 
 Cell Biolabs 
(STA-337) 
 
50-
200 
50 - 2 h 30 min 
Direct 
competitiv
e between 
IBL 
(CM500431) 
23.4 
- 
3000 
2.7 7.2% / 15.5% 2 h 
SO and AP-
ISO 
CD Creative 
Diagnost. 
(DEIA6463) 
40 - 
100 
40 12% / 20% 3 h 30 min 
Substrate:  Enzo Life 3- 6.71 9.7-13.1% < 3h 
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pNPP Sciences 
ADI-900-
069 
 
5000
0 
Direct 
competitiv
e between   
CD Creative 
Diagnost. 
(DEIA5014) 
40 - 
100 
10 12% / 20% 3 h 30 min 
ISO and 
AChE-ISO.  
Substrate: 
thiocholine 
CD Creative 
Diagnost. 
(DEIA6464) 
40-
100 
16.3 12%/20% 3 h 30 min 
Abbreviations: MDC, minimum detectable concentration; ISO, 8 isoprostane; HRP-ISO, 
peroxidase-labeled isoprostane; TMB, 3,3´5,5´-tetramethylbenzidine; AChE-ISO,  
acetilcholinesterase-labeled isoprostane; pNPP, 4-nitrophenyl phosphate. 
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Table 2. Determination of ISO in human serum samples with anti-ISO-
CNHs/SPCE immunosensors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lyophilized spiked serum 
 
 
ISO, pg/mL 
 
ISO found, pg/mL (n=3) Recovery, % 
30 30 ± 4 100 ± 1 
35 33 ± 7 95 ± 6 
40 42 ± 3 101 ± 4 
 
 
Real human serum 
  
Type 
Immunosensor, 
pg/mL (n=6) 
ELISA, 
pg/mL (n=6) 
Healthy male 
(SG610-2, BBI) 
 
403 ± 7 408 ± 5 
Healthy female 
(SG609-2, BBI) 
394 ± 4 398 ± 3 
